Log In
person
Celltrion Inc
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2017
| Reporting Segmentarrow_drop_up | Product Line | Amount | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount | Percentage |
| Biopharma-ceutical medicines |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
828.92M | 86.49% |
| Chemical medicines |
Generic Pharmaceuticals
These companies manufacture generic drugs.
|
129.53M | 13.51% |
| keyboard_arrow_down |
Biopharma-ceutical medicines
Biosimilars; sold through distributor
|
828.92M | 86.49% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||
| keyboard_arrow_down |
Chemical medicines
Generic Pharmaceuticals
|
129.53M | 13.51% |
| keyboard_arrow_right |
These companies manufacture generic drugs.
|
||